Found 14 matching trials
SAbR For Oligo-Progressive Renal Cell Cancer. PHASE2 Metastatic kidney cancer patients on systemic therapy often develop resista...
Show More Location
University of Texas Southwestern Medical Center
Learn More & Join Trial
Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy PHASE1 The goal of this clinical trial is to assess whether the addition of preope...
Show More Location
The Department of Radiation Oncology,the Second Affiliated Hospital of Zhejiang University School of Medicine
Learn More & Join Trial
Palliative Radiation for Advanced Cervical Cancer NA The present study is proposed to compare a rapid fractionation schedule of ...
Show More Location
Tata Memorial Hospital
Learn More & Join Trial
Neoadjuvant Chemotherapy + PD-1 Inhibitor+Different Radiotherapy Fractionations for HR+/HER2- Breast Cancer PHASE2 For the hormone receptor-positive (HR+)/human epidermal growth factor recep...
Show More Location
Multiple Locations
Learn More & Join Trial
Combination of SFRT, PD-L1 Inhibitor, and Anti-VEGF in Advanced Hepatocellular Carcinoma NA PD-1 inhibitor plus anti-VEGFR has become the established standard first-li...
Show More Location
Guiping People's Hospital
Learn More & Join Trial
Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC) PHASE2 The purpose of this study is to evaluate the efficacy of neoadjuvant immuno...
Show More Status
Active Not Recruiting
Location
University of San Diego
Learn More & Join Trial
Combination of Chemotherapy and Adaptive MR-Guided Radiotherapy to Improve Outcomes in Patients With Esophageal Adenocarcinoma PHASE1 Rationale: Esophageal cancer (EC) is the seventh most frequently diagnosed ...
Show More Location
University Medical Center Utrecht
Learn More & Join Trial
Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases PHASE2 The goal of this clinical trial is to to learn about different combinations...
Show More Location
Weill Cornell Medicine/NewYork-Presbyterian Hospital
Learn More & Join Trial
Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer PHASE2 This is a prospective radiation dose-finding, phase 2 expansion study of th...
Show More Location
University of North Carolina
Learn More & Join Trial
An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer PHASE2 An open label, randomized study of neoadjuvant nivolumab and chemotherapy, ...
Show More Status
Active Not Recruiting
Location
Washington University in St. Louis
Learn More & Join Trial